Authored By: Sarah
14 Nov 2024

increasing adoption of innovative marketing strategies is driving the Female Contraceptive Market

Latest News:- Female Contraceptive Market: Offline is expected to lead the Distribution Channel segment during 2024-2028

Technavio analyzes that the Female Contraceptive Market is expected to grow at a CAGR of 4.6% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 4571.5 million.There are various factors that contribute to the growth of the market. The female contraceptive market is witnessing significant growth due to the increasing adoption of innovative marketing strategies. Companies are leveraging digital platforms, social media, and targeted advertising to reach potential customers. Additionally, the development of new and effective contraceptive methods continues to drive demand. These factors are contributing to the expansion of the market and the introduction of new products. Overall, the female contraceptive market is poised for continued growth in the coming years.

In the female contraceptive market, merchandisers, including specialty stores, hypermarkets, supermarkets, and convenience stores, are experiencing growth due to increasing consumer awareness and availability of various contraceptive options. These options encompass intrauterine devices (IUDs), hormonal and non-hormonal intrauterine devices, subcutaneous implants, and late-stage pipeline therapies. Merchandisers are broadening their product offerings to include sexual wellness categories, such as condoms, contraceptives, personal lubricants, vibrators, and sexual enhancement supplements. Expansion into local and regional markets is a strategic move to boost sales through offline channels. Key contraceptive classes, such as hormonal and non-hormonal, face ongoing challenges related to adverse reactions and compliance and adherence. Despite these challenges, the market is projected to grow steadily, driven by the demand for effective and accessible birth control solutions. Drug developers continue to innovate, addressing these challenges through the development of new technologies and formulations. 

Know which region is leading the market growth by requesting a sample report

Female Contraceptive Market Segmentation

  • Distribution Channel
    • Offline
    • Online
  • Product
    • Female contraceptive devices
    • Female contraceptive drugs
  • Geography
    • North America
    • Europe
    • APAC
    • South America
    • Middle East and Africa

Top Performing Companies

As per our research findings, here are some of the key competitors that are leading the industry

  • AbbVie Inc.
  • Afaxys Pharma LLC
  • Agile Therapeutics Inc.
  • Amgen Inc.
  • Ansell Ltd.
  • Bayer AG
  • The Cooper Companies Inc.
  • Cupid Ltd.
  • Exeltis USA Inc.
  • Johnson and Johnson Services Inc.
  • Mayer Laboratories Inc.
  • Medisafe Distribution Inc.
  • Merck and Co. Inc.
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Reckitt Benckiser Group Plc
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Veru Inc.
  • Viatris Inc.

Find out what is trending in the market by accessing the free PDF report

Research Analysis Overview

The female contraceptive market caters to the needs of the female population through various contemporary methods, including intrauterine devices (IUDs) and oral contraceptives. The contraceptive pipeline is robust, with new offerings such as Dienogest + ethinylestradiol PR and Estelle (drospirenone + estetrol). Drospirenone is also used in oral contraceptives and transdermal patches. Female vitiligo patients and those at risk of osteoporosis require special consideration. A patient enrolment milestone was reached in a study on oral contraceptives' success. Topical contraceptives like vaginal gels, transdermal patches, and spermicides, as well as medications like contraceptive injections, diaphragms, and caps, are also available. Birth control methods include surgery, but most prefer medications. Unplanned births among teenagers and young population remain a concern, highlighting the importance of accessible and effective contraceptive options.

Market Research Overview

The Female Contraceptive Market is a significant segment within the broader Global Personal Care Products industry. Key products include Intrauterine Devices (IUDs) and oral contraceptives, which cater to the reproductive health needs of a substantial portion of the global female population. The contraceptive pipeline features innovative offerings, such as Estelle (drospirenone + estetrol), which differentiates from traditional oral contraceptives containing drospirenone. However, considerations for specific patient populations, such as those with vitiligo or osteoporosis, necessitate ongoing research and development. Milestones, such as successful patient enrolment in clinical trials, are crucial indicators of progress in the oral contraceptives market. Additionally, alternative delivery methods, including transdermal patches and vaginal gels, expand the contraceptive drugs landscape. The market's growth is influenced by increasing disposable income, enabling greater expenditure on personal and lifestyle-related products.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Reasons to Consider Purchasing Technavio Market Research Report

  • Current Market Insights: Our reports offer valuable information on the latest market intelligence, competitor strategies, trends, industry changes, customer preferences, and forecasted market opportunities to aid in informed business decisions.

  • Extensive Experience: With over 20 years in market research, Technavio is a trusted name, having published more than 21,000 reports across various industries and regions.

  • High ROI Through In-Depth Research: Technavio specializes in tailored market research reports to meet specific business needs, exploring particular markets, product segments, and demographics. We are also recognized for delivering significant returns on investment through our comprehensive data collection at affordable prices.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.